Rationales, values, and DSM-IV: The case of 'medication-induced movement disorders'

Comprehensive Psychiatry

Volumn 37, Issue 6, 1996, Pages 441-451

  Sadler, John Z ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; MOTOR DYSFUNCTION; NOMENCLATURE; PRACTICE GUIDELINE;

EID: 0029803571     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(96)90028-0     Document Type: Article

References (59)

1. Widiger TA, Frances AJ, Pincus HA, Davis WW. DSM-IV literature reviews: rationale, process, and limitations. J Psychopathol Behav Assess 1990;129:189-202.
2. Widiger TA, Frances AJ, Pincus HA, Davis WW, First MB. Toward an empirical classification for the DSM-IV. J Abnorm Psychol 1991;1003:280-288.
3. Widiger T, Trull TJ. The scholarly development of DSM-IV. In: Costa e Suva JA, Nadelson C (eds): International Review of Psychiatry. Vol. 1. Washington, DC: American Psychiatric Press 1993;59-78.
4. Frances A, Widiger TA, Pincus HA. The development of DSM-IV. Arch Gen Psychiatry 1989;46:373-375.
5. Frances A, First MB, Widiger TA, Miele GM, Tilly SM, Davis WW, et al. An A-Z guide to DSM-IV conundrums. J Abnorm Psychol 1991;1003:407-412.
6. Frances A, First M, Pincus HA, Widiger T, Davis W. An introduction to DSM-IV. Hosp Community Psychiatry 1990;415:493-494.
7. Pincus HA, Frances A, Davis WW, First MB, Widiger TA. DSM-IV and new diagnostic categories: holding the line on proliferation. Am J Psychiatry 1992;149:112-117.
8. Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds). DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994.
9. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. (DSM-IV). Washington, DC: American Psychiatric Press, 1994.
10. Task Force on DSM-IV. DSM-IV Options Book: Work in Progress 9/1/91. Washington, DC: American Psychiatric Press, 1991.
11. Frances AF, Weiden PJ, Ross R. Introduction to Section IV: medication-induced movement disorders. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:495-504.
12. Weiden PJ. Neuroleptic-induced parkinsonism. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:505-532.
13. Addonizio G, Susman V. Neuroleptic malignant syndrome. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:533-544.
14. Casey DE. Neuroleptic-induced acute dystonia. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:545-560.
15. Adler LA, Angrist B. Neuroleptic-induced acute akathisia. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:561-572.
16. Jeste DV, Yassa R. Neuroleptic-induced tardive dyskinesia. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:573-582.
17. Gelenberg AJ, Jefferson JW. Lithium tremor. In: Widiger TA, Frances AJ, Pincus HA, First MB, Ross R, Davis W (eds): DSM-IV Sourcebook. Vol. 1. Washington, DC: American Psychiatric Press, 1994:583-596.
18. Kendler KS. Toward a scientific psychiatric nosology: strengths and limitations. Arch Gen Psychiatry 1990;47:969-973.
19. Proctor RN. Value-Free Science? Purity and Power in Modern Knowledge. Cambridge, MA: Harvard University Press, 1991.
20. Brown HI. Perception, Theory, and Commitment: The New Philosophy of Science. Chicago, IL: University of Chicago Press, 1977.
21. Longino H. Science as Social Knowledge: Values and Objectivity in Scientific Inquiry. Princeton, NJ: Princeton University Press, 1990.
22. Merton RK. The normative structure of science. In Storer NW (ed): The Sociology of Science: Theoretical and Empirical Investigations. Chicago, IL: University of Chicago Press, 1973;267-278.
23. Shapin S. Trust, honesty, and the authority of science. In Bulger RE, Bobby VE, Fineberg HV (eds): Society's Choices: Social and Ethical Decision Making in Biomedicine. Washington, DC: Institute of Medicine/National Academy Press, 1995:388-408.
24. Kuhn TS. The Structure of Scientific Revolutions. Ed. 2. Chicago, IL: University of Chicago Press, 1970.
25. Rosenberg CE, Golden J (eds). Framing Disease: Studies in Cultural History. New Brunswick, NJ: Rutgers University Press, 1992.
26. Grinnell F. The Scientific Attitude. Ed. 2. New York, NY: Guilford, 1992.
27. Fleck L. In Trenn TJ, Merton RK (eds): Genesis and Development of a Scientific Fact. Chicago, IL: University of Chicago Press, 1970.
28. Kuhn TS. Objectivity, value judgment, and theory choice. In: The Essential Tension. Chicago, IL: University of Chicago Press, 1977:320-329.
29. Agich GJ. Disease and value: a rejection of the value-neutrality thesis. Theor Med 1983;4:27-41.
30. Agich GJ. Evaluative judgments and personality disorder. In: Sadler JZ, Wiggins OP, Schwartz MA (eds): Philosophical Perspectives on Psychiatric Diagnostic Classification. Baltimore, MD Johns Hopkins University Press, 1994:233-245.
31. Fulford KWM. Moral Theory and Medical Practice. Cambridge, UK: Cambridge University Press, 1989.
32. Fulford KWM. The concept of disease. In: Bloch S, Chodoff P (eds): Psychiatric Ethics. Ed. 2. Oxford, UK: Oxford University Press, 1991:77-99.
33. Fulford KWM. Closet logics: Hidden conceptual elements in the DSM and ICD classifications of mental disorders. In: Sadler JZ, Wiggins OP, Schwartz MA (eds): Philosophical Perspectives on Psychiatric Diagnostic Classification. Baltimore, MD: Johns Hopkins University Press, 1994:211-232.
34. Heelan P. Space Perception and the Philosophy of Science. Berkeley, CA: University of California Press, 1983.
35. King LS. What is disease? Philos Sci 1954;21:193-203.
36. Sadler JZ, Wiggins OP, Schwartz MA. Introduction. In: Sadler JZ, Wiggins OP, Schwartz MA (eds): Philosophical Perspectives on Psychiatric Diagnostic Classification. Baltimore, MD: Johns Hopkins University Press, 1994:1-15.
37. Sedgwick P. Psycho Politics. New York, NY: Harper and Row, 1982.
38. Sadler JZ, Hulgus YF, Agich GJ. On values in recent American psychiatric classification. J Med Philos 1994;19: 261-277.
39. Putnam H. Reason, Truth, and History. Cambridge, UK: Cambridge University Press, 1981.
40. Radden J. A review of recent nosologic controversy in psychiatry. Philos Psychiatry Psychol 13:193-200,1994.
41. Millon T, Klerman G (eds). Contemporary Directions in Psychopathology: Towards the DSM-IV. New York, NY: Guilford, 1987.
42. Spitzer RL, Williams JBW. Having a dream: a research strategy for DSM-IV. Arch Gen Psychiatry 1988;45: 871-874.
43. Spitzer RL. An outsider-insider's views about revising the DSMs. J Abnorm Psychol 1991;1003:294-296.
44. Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben-Yehuda Y, et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis 1991;179:526-533.
45. Fromm-Auch D. Comparison of unilateral and bilateral ECT: evidence for selective memory impairment. Br J Psychiatry 1982;141:608-613.
46. Squire LR, Slater PC. Bilateral and unilateral ECT: effects on verbal and nonverbal memory. Am J Psychiatry 1978;11:1316-1320.
47. Squire L. ECT and memory dysfunction. In: Lerer B, Werner RD, Belmaker RH (eds): ECT: Basic Mechanisms. London, UK: John Libbey, 1984:156-163.
48. Bixler EO, Kales A, Manfredi R, Vgontzas AM, Tyson K, Kales JD. Next-day memory impairment with triazolam use. Lancet 1991;337:827-831.
49. Morris HH, Estes ML. Traveler's amnesia: transient global amnesia secondary to triazolam. JAMA 1987;258:945-946.
50. Patterson J. Triazolam syndrome in the elderly. South Med J 1987;80:1425-1426.
51. Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry 1992;53(12 Suppl):69-79.
52. Shader RI, Greenblatt DJ. Triazolam and anterograde amnesia: all is not well in the Z-zone. J Clin Psychopharmacol 1983;3:273.
53. Van der Kroef C. Reactions to triazolam. Lancet 1979;2:526 (letter).
54. Wysowski D, Barash D. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's spontaneous reporting system. Arch Int Med 1991;151: 2003-2008.
55. Hall RC, Popkin MK, Stickney K, Gardner ER. Presentation of the steroid psychosis. J Nerv Ment Dis 1979;1674:229-236.
56. Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989;30:135-139.
57. Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 1978;35:1333-1339.
58. Ling MHM, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy. Arch Gen Psychiatry 1981;38:471-477.
59. Kendell RE. What is a case? Food for thought for epidemiologists. Arch Gen Psychiatry 1988;47:969-973.